ORGO

ORGO Operating Cash Flow (Statement)

$31.97MTTM · USD

Period ending:

ORGO FY Cash from OperationsUSD
ORGO FY Cash from Operations2015-12-31: -$10.19M2016-12-31: -$562.23K2017-12-31: -$586.60K2018-12-31: -$60.74M2019-12-31: -$33.53M2020-12-31: $5.47M2021-12-31: $61.98M2022-12-31: $24.86M2023-12-31: $30.92M2024-12-31: $14.21M2025-12-31: -$10.31M$61.98M-$60.74M
2015-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ORGO operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 11 observations from Dec 31, 2015 to Dec 31, 2025.

Organogenesis Holdings Inc Class A Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-10,309,000
14,208,000
30,917,000
24,859,000
61,978,000
5,466,000
-33,528,000
-60,739,000
-586,604
-562,233
-10,193,000

Compare operating cash flow (statement)

All ORGO financial metrics · ORGO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.